Manulife posts 16% core EPS growth in second quarter 2026

The insurer reported C$1.9 billion in core earnings, C$2.1 billion in net income, double-digit insurance new business growth and a 136% LICAT ratio, while Global WAM net inflows slowed to C$0.4 billion.

Summary

Manulife Financial Corporation reported stronger second-quarter 2026 results, with core earnings of C$1.9 billion and core EPS of C$1.09, up 12% and 16% respectively on a constant exchange rate basis from a year earlier. Net income attributed to shareholders rose to C$2.1 billion from C$1.789 billion in 2Q25, while EPS increased 22% to C$1.20. Core ROE reached 16.3%, ROE was 18.0%, and the LICAT ratio, a Canadian life insurer capital measure, stood at 136% as of June 30, 2026. Insurance sales momentum remained broad-based, with APE sales up 21%, new business CSM up 16%, and NBV up 10%, while Global Wealth and Asset Management recorded C$0.4 billion in net inflows versus C$0.9 billion a year earlier. Management linked the quarter to distribution expansion, product launches and wider AI use, and said a long-term care reinsurance transaction announced on Aug. 5 is expected to close in Q4 2026, subject to regulatory approvals, further reducing risk. For the first half of 2026, Manulife returned C$2.6 billion to shareholders through dividends and share buybacks, while CSM net of non-controlling interests rose 20% year over year to C$27,263 million and post-tax CSM net of NCI reached C$22,667 million.

Terms & Concepts
  • LICAT ratio: The Life Insurance Capital Adequacy Test, a Canadian regulatory measure of capital strength for life insurers.
  • CSM: Contractual service margin, an insurance accounting measure that represents unearned profit to be recognized over time.
  • APE sales: Annualized premium equivalent, a standard life insurance sales measure that combines regular premiums and a portion of single premiums.